Drug induced lupus associated with Trastuzumab emtansine in a patient with metastatic breast cancer
Drug-induced lupus is a clinical syndrome that shares similar features with systemic lupus erythematosus (SLE). The majority of patients present with symptoms such as arthralgia and myalgia. Hydralazine and procainamide are high-risk drugs for drug-induced lupus. Symptoms usually develop after months or years of use, but may also develop suddenly. Our patient also received TDM-1 treatment for 18 months. We present a case of TDM-1-associated drug-induced lupus in a patient with metastatic breast cancer. This is the first case of TDM-1-related drug-induced lupus reported in the literature.
Authors
- Talat Aykut (ORCID: https://orcid.org/0000-0002-9614-0651)
- Özlem Şahin (ORCID: https://orcid.org/0000-0001-5318-0066)
- Zeliha Çelik (ORCID: https://orcid.org/0000-0003-2550-7791)
- Mehmet Artaç (ORCID: https://orcid.org/0000-0003-2335-3354)
- Murat Araz (ORCID: https://orcid.org/0000-0002-4632-9501)
- Melek Karakurt Eryılmaz (ORCID: https://orcid.org/0000-0003-2597-5931)
- Oğuzhan Yıldız (ORCID: https://orcid.org/0000-0002-4057-3108)
- Ali Fuat Gürbüz (ORCID: https://orcid.org/0000-0003-1455-471X)
- Naciye Hilal Büyükboyacı
Institutions
- Necmettin Erbakan University (TR)
Publication Details
- Journal
- Journal of Oncology Pharmacy Practice
- Published
- 2024-09-23
- DOI
- https://doi.org/10.1177/10781552241276191
- Citations
- 1
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 0.28